A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Name: A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications
Published: 2023
License: Public Domain

Amgen · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

non-squamous non-small cell lung cancer, epithelial ovarian cancer, claudin 6-positive advanced/metastatic malignant solid tumors, malignant solid tumors, claudin 6-positive, amg 794, cldn6, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Related documents